Raymond James Financial Services Advisors, Inc. Chroma Dex Corp. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$3.93 - $5.5 $342,023 - $478,659	-87,029 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$4.01 - $5.56 $1,604 - $2,224	400 Added 0.46%	87,029 $349,000
Q2 2020 Jul 17, 2020	SELL	$3.0 - $5.52 $5,775 - $10,626	-1,925 Reduced 2.17%	86,629 $398,000
Q1 2020 Apr 21, 2020	SELL	$2.54 - $4.75 $23,037 - $43,082	-9,070 Reduced 9.29%	88,554 $289,000
Q3 2019 Nov 07, 2019	BUY	$3.83 - $4.72 $373,899 - $460,785	97,624 New	97,624 $384,000
Q3 2017 Oct 26, 2017	SELL	$2.91 - $4.71 $30,071 - $48,673	-10,334 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	10,334	10,334 $39,000

Others Institutions Holding CDXC

# of Institutions

129

Shares Held

21.9M

Call Options Held

203K

Put Options Held

23.9K

Vanguard Group Inc Valley Forge, PA

3.39M
Shares

$19.7 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.12M
Shares

$18.1 Million
0.0% of portfolio
Tieton Capital Management, LLC Yakima, WA

2.59M
Shares

$15.1 Million
5.52% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.3M
Shares

$7.54 Million
0.14% of portfolio
Geode Capital Management, LLC Boston, MA

1.15M
Shares

$6.72 Million
0.0% of portfolio

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $398M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account